A detailed history of Intech Investment Management LLC transactions in Candel Therapeutics, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 23,871 shares of CADL stock, worth $131,051. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,871
Previous 28,566 16.44%
Holding current value
$131,051
Previous $161,000 25.47%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025

SELL
$4.39 - $6.04 $20,611 - $28,357
-4,695 Reduced 16.44%
23,871 $120,000
Q1 2025

May 20, 2025

BUY
$5.65 - $12.21 $161,397 - $348,790
28,566 New
28,566 $161,000

Others Institutions Holding CADL

About Candel Therapeutics, Inc.


  • Ticker CADL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,891,900
  • Market Cap $159M
  • Description
  • Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...
More about CADL
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.